Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
van der Hoek J, de Herder WW, Feelders RA, van der Lely AJ, Uitterlinden P, Boerlin V, Bruns C, Poon KW, Lewis I, Weckbecker G, Krahnke T, Hofland LJ, Lamberts SW. van der Hoek J, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2004 Feb;89(2):638-45. doi: 10.1210/jc.2003-031052. J Clin Endocrinol Metab. 2004. PMID: 14764775 Free article. Clinical Trial.
Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
Janssen JA, Wildhagen MF, Ito K, Blijenberg BG, Van Schaik RH, Roobol MJ, Pols HA, Lamberts SW, Schröder FH. Janssen JA, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2004 Sep;89(9):4391-6. doi: 10.1210/jc.2004-0232. J Clin Endocrinol Metab. 2004. PMID: 15356036
Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels.
Feelders RA, Bidlingmaier M, Strasburger CJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW, van der Lely AJ, de Herder WW. Feelders RA, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2005 Dec;90(12):6480-9. doi: 10.1210/jc.2005-0901. Epub 2005 Sep 13. J Clin Endocrinol Metab. 2005. PMID: 16159936
Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
van Hoek M, Hofland LJ, de Rijke YB, van Nederveen FH, de Krijger RR, van Koetsveld PM, Lamberts SW, van der Lely AJ, de Herder WW, Feelders RA. van Hoek M, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2009 Feb;94(2):428-33. doi: 10.1210/jc.2008-1712. Epub 2008 Nov 18. J Clin Endocrinol Metab. 2009. PMID: 19017754
New somatostatin analogs: will they fulfil old promises?
Lamberts SW, van der Lely AJ, Hofland LJ. Lamberts SW, et al. Eur J Endocrinol. 2002 May;146(5):701-5. doi: 10.1530/eje.0.1460701. Eur J Endocrinol. 2002. PMID: 11980627 Free article. Review. No abstract available.
732 results